SCHEMBL18435147

SCHEMBL18435147

CCN[C@@H](Cc1ccccc1)C(=O)Nc1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ GPR142 Q7Z601 2/20 0.57
▸ CYP2D6 P10635 2/20 0.52
▸ MAPT P10636 1/20 0.52
▸ MEN1 O00255 2/20 0.51
▸ KMT2A Q03164 2/20 0.51
▸ NPC1 O15118 1/20 0.51
▸ RAB9A P51151 1/20 0.51
▸ SMN1; SMN2 Q16637 1/20 0.50
▸ HDAC8 Q9BY41 1/20 0.49
▸ CYP1A2 P05177 1/20 0.49
▸ CYP3A4 P08684 1/20 0.49
▸ CYP2C9 P11712 1/20 0.49
▸ CYP2C19 P33261 1/20 0.49
▸ FPR2 P25090 6/20 0.49
▸ SIGMAR1 Q99720 1/20 0.49
▸ IDO1 P14902 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23092423 0.86 MEN1 (0.49) GPR142CYP2D6MEN1KMT2ANPC1
SCHEMBL23092425 0.86 MEN1 (0.49) GPR142CYP2D6MEN1KMT2ANPC1
SCHEMBL18435163 0.84 CTSS (0.52) HDAC8SIGMAR1
SCHEMBL16254380 0.84 CYP2D6 (0.54) GPR142CYP2D6MAPTMEN1KMT2A
SCHEMBL22025427 0.83 KMT2A (0.59) MAPTKMT2AHDAC8SIGMAR1
SCHEMBL839840 0.82 SIGMAR1 (0.56) CYP1A2FPR2SIGMAR1
SCHEMBL1958454 0.82 SIGMAR1 (0.56) CYP1A2FPR2SIGMAR1
SCHEMBL7271174 0.82 SIGMAR1 (0.56) CYP1A2FPR2SIGMAR1
SCHEMBL16252298 0.81 MEN1 (0.55) GPR142CYP2D6MAPTMEN1KMT2A
Hydrochloric Acid SCHEMBL393423 0.80 SIGMAR1 (0.55) CYP1A2FPR2SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2861581-B9 1,2,3,4-Tetrahydroisoquinoline-pyrrolidine derivatives as antagonists of apoptosis (IAPs) for the treatment of cancer. BRISTOL MYERS SQUIBB CO (US) 2017-08-30 — — EP disclosed
EP-2861581-B1 1,2,3,4-Tetrahydroisoquinoline-pyrrolidine derivatives as antagonists of apoptosis (IAPs) for the treatment of cancer. BRISTOL MYERS SQUIBB CO (US) 2017-02-01 — — EP disclosed
Send feedback